APA

Jonkers I. J. A. M., Smelt A. H. M., Ledeboer M., Hollum M. E., Biemond I., Kuipers F., Stellaard F., Boverhof R., Meinders A. E., Lamers C. H. B. W. & Masclee A. A. M. (20030220). Gall bladder dysmotility: a risk factor for gall stone formation in hypertriglyceridaemia and reversal on triglyceride lowering therapy by bezafibrate and fish oil. : Gut.

Chicago

Jonkers I J A M, Smelt A H M, Ledeboer M, Hollum M E, Biemond I, Kuipers F, Stellaard F, Boverhof R, Meinders A E, Lamers C H B W and Masclee A A M. 20030220. Gall bladder dysmotility: a risk factor for gall stone formation in hypertriglyceridaemia and reversal on triglyceride lowering therapy by bezafibrate and fish oil. : Gut.

Harvard

Jonkers I. J. A. M., Smelt A. H. M., Ledeboer M., Hollum M. E., Biemond I., Kuipers F., Stellaard F., Boverhof R., Meinders A. E., Lamers C. H. B. W. and Masclee A. A. M. (20030220). Gall bladder dysmotility: a risk factor for gall stone formation in hypertriglyceridaemia and reversal on triglyceride lowering therapy by bezafibrate and fish oil. : Gut.

MLA

Jonkers I J A M, Smelt A H M, Ledeboer M, Hollum M E, Biemond I, Kuipers F, Stellaard F, Boverhof R, Meinders A E, Lamers C H B W and Masclee A A M. Gall bladder dysmotility: a risk factor for gall stone formation in hypertriglyceridaemia and reversal on triglyceride lowering therapy by bezafibrate and fish oil. : Gut. 20030220.